We improve patient outcomes by empowering healthcare professionals to make better informed clinical decisions, leading to more efficient patient triage.
The suPAR biomarker predicts negative patient outcomes across diseases by measuring the immune system’s activation level. suPARnostic® is a reliable prognostic tool that enables healthcare professionals to make quick and informed patient triaging decisions at hospital emergency departments.
suPARnostic® empowers healthcare professionals to lead patient triage with confidence by making better informed decisions across diseases, backed by reliable biological data.
Implementing suPAR in clinical care saves critical resources and valuable time, and results in vastly
reduced healthcare costs, more efficient triage, and better patient outcomes.
At hospital emergency departments, suPAR delivers faster and safer patient discharges, reduces readmissions, avoids unnecessary admissions, and lowers hospital length of stay.
Seamlessly implemented by clinician and laboratory technicians, suPARnostic products fit existing workflows in hospitals, are approved for all the major clinical chemistry analyzers, and delivers results in less than 20 minutes.
Industry
Biotechnology Research, Pharmaceutical veterinary preparations, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Chemotherapeutic preparations, Immunological preparations, Pharmaceutical preparations for the central and autonomic nervous system and anaesthetics, Pharmaceutical preparations for the cardiovascular system
HQ Location
Banevænget 13
Birkerød, Capital Region 3460, DK